应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FULC Fulcrum Therapeutics
交易中 07-22 13:26:06 EDT
8.33
+0.33
+4.13%
最高
8.35
最低
8.08
成交量
17.18万
今开
8.13
昨收
8.00
日振幅
3.38%
总市值
5.18亿
流通市值
3.64亿
总股本
6,215万
成交额
141.15万
换手率
0.39%
流通股本
4,366万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Fulcrum Therapeutics, Inc.盘中异动 早盘急速上涨6.98%
自选股智能写手 · 07-16
Fulcrum Therapeutics, Inc.盘中异动 早盘急速上涨6.98%
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.62%报8.46美元
自选股智能写手 · 07-16
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.62%报8.46美元
Fulcrum Therapeutics, Inc.盘中异动 大幅上涨5.13%
自选股智能写手 · 07-13
Fulcrum Therapeutics, Inc.盘中异动 大幅上涨5.13%
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.05%报6.86美元
自选股智能写手 · 07-11
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.05%报6.86美元
Fulcrum Therapeutics, Inc.盘中异动 急速上涨5.12%
自选股智能写手 · 07-10
Fulcrum Therapeutics, Inc.盘中异动 急速上涨5.12%
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报6.48美元
自选股智能写手 · 06-27
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报6.48美元
Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.05%报6.02美元
自选股智能写手 · 06-26
Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.05%报6.02美元
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨6.08%报7.85美元
自选股智能写手 · 06-12
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨6.08%报7.85美元
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨10.26%
自选股智能写手 · 05-28
Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨10.26%
Fulcrum Therapeutics(FULC.US)获坎托菲茨杰拉德公司首次覆盖,给予增持评级, 目标价23.00美元。
智通财经 · 05-20
Fulcrum Therapeutics(FULC.US)获坎托菲茨杰拉德公司首次覆盖,给予增持评级, 目标价23.00美元。
Fulcrum Therapeutics, Inc.2024财年第一财季实现净利润-26.87百万美元,同比减少8.43%
自选股智能写手 · 05-20
Fulcrum Therapeutics, Inc.2024财年第一财季实现净利润-26.87百万美元,同比减少8.43%
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.85%报7.78美元
自选股智能写手 · 05-14
Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.85%报7.78美元
美国研究综述-Akoya Biosciences、波士顿啤酒公司、胜利资本控股公司
Reuters · 05-14
美国研究综述-Akoya Biosciences、波士顿啤酒公司、胜利资本控股公司
高盛:上调Fulcrum Therapeutics(FULC.US)评级,由中性调整至买入评级, 目标价15.00美元。
智通财经 · 05-14
高盛:上调Fulcrum Therapeutics(FULC.US)评级,由中性调整至买入评级, 目标价15.00美元。
BUZZ--美国股票走势-Annexon、MKS Instruments、Robinhood
Reuters · 05-14
BUZZ--美国股票走势-Annexon、MKS Instruments、Robinhood
Fulcrum Therapeutics, Inc.盘中异动 股价大涨11.71%
自选股智能写手 · 05-13
Fulcrum Therapeutics, Inc.盘中异动 股价大涨11.71%
BUZZ--美国股票走势-GameStop, AC Immune , Fulcrum Therapeutics
Reuters · 05-13
BUZZ--美国股票走势-GameStop, AC Immune , Fulcrum Therapeutics
BUZZ--美国股票走势-GameStop, AC Immune , Fulcrum Therapeutics
Reuters · 05-13
BUZZ--美国股票走势-GameStop, AC Immune , Fulcrum Therapeutics
BUZZ-Fulcrum Therapeutics 因与赛诺菲达成肌肉疾病药物许可协议而上涨
Reuters · 05-13
BUZZ-Fulcrum Therapeutics 因与赛诺菲达成肌肉疾病药物许可协议而上涨
Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.22%
自选股智能写手 · 04-25
Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.22%
公司概况
公司名称:
Fulcrum Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fulcrum Therapeutics, Inc.于2015年8月18日在特拉华州注册成立。他们是一家临床阶段的生物制药公司,致力于改善未满足医疗需求的遗传性疾病患者的生活,最初的重点是罕见疾病。他们开发了一种专有产品引擎,用于系统地识别和验证可能调节基因表达的细胞药物靶点,以治疗遗传定义疾病的已知根本原因。他们正在使用他们的产品引擎来识别可被小分子吸毒的目标,而不管基因错误表达的特定潜在机制。他们已经确定了治疗面肩肱型肌营养不良症(FSHD)和某些血红蛋白病(即镰状细胞病,SCD和b-地中海贫血)的根本原因的药物靶点。
发行价格:
--
{"stockData":{"symbol":"FULC","market":"US","secType":"STK","nameCN":"Fulcrum Therapeutics","latestPrice":8.33,"timestamp":1721669150661,"preClose":8,"halted":0,"volume":171809,"delay":0,"floatShares":43662806,"shares":62153638,"eps":-1.606871,"marketStatus":"交易中","marketStatusCode":2,"change":0.33,"latestTime":"07-22 13:26:06 EDT","open":8.13,"high":8.35,"low":8.08,"amount":1411450.622879,"amplitude":0.03375,"askPrice":8.34,"askSize":601,"bidPrice":8.31,"bidSize":549,"shortable":3,"etf":0,"ttmEps":-1.606871,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":1563422400000,"adjPreClose":8,"preHourTrading":{"tag":"盘前","latestPrice":8.16,"preClose":8,"latestTime":"09:29 EDT","volume":141,"amount":1150.56,"timestamp":1721654999999},"postHourTrading":{"tag":"盘后","latestPrice":8,"preClose":8,"latestTime":"16:02 EDT","volume":9664,"amount":77312,"timestamp":1721419340222},"volumeRatio":0.320924,"impliedVol":0.5489,"impliedVolPercentile":0.1873},"requestUrl":"/m/hq/s/FULC/wiki","defaultTab":"wiki","newsList":[{"id":"2451997713","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘急速上涨6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451997713","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451997713?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:30","pubTimestamp":1721136652,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时30分,Fulcrum Therapeutics, Inc.股票出现异动,股价快速拉升6.98%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Scisparc Ltd.涨幅较大,Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为1125.77%、476.40%、71.52%,振幅较大的相关个股有Hcw Biologics Inc.、Silo Pharma, Inc.、Calidi Biotherapeutics, Inc.,振幅分别为13.56%、12.15%、8.00%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162130529681d2eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162130529681d2eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2451676843","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.62%报8.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451676843","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451676843?lang=zh_cn&edition=full","pubTime":"2024-07-16 01:43","pubTimestamp":1721065420,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日01时43分,Fulcrum Therapeutics, Inc.股票出现波动,股价快速拉升5.62%。截至发稿,该股报8.46美元/股,成交量36.9579万股,换手率0.59%,振幅4.74%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。其相关个股中,Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Scinai Immunotherapeutics Ltd涨幅较大,Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为3337.72%、159.02%、133.43%,振幅较大的相关个股有Aeon Biopharma, Inc.、Scinai Immunotherapeutics Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为150.36%、91.37%、74.53%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160143419681cdc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160143419681cdc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","FULC"],"gpt_icon":0},{"id":"2451542005","title":"Fulcrum Therapeutics, Inc.盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451542005","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451542005?lang=zh_cn&edition=full","pubTime":"2024-07-13 02:04","pubTimestamp":1720807456,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日02时04分,Fulcrum Therapeutics, Inc.股票出现异动,股价快速上涨5.13%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.46%。其相关个股中,Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Qualigen Therapeutics, Inc.、Soligenix, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为3999.19%、111.41%、99.97%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Xortx Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为147.88%、78.88%、65.30%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407130204169681c6ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407130204169681c6ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","FULC"],"gpt_icon":0},{"id":"2450484887","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.05%报6.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450484887","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450484887?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:32","pubTimestamp":1720629147,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时32分,Fulcrum Therapeutics, Inc.股票出现异动,股价快速拉升5.05%。截至发稿,该股报6.86美元/股,成交量19.6663万股,换手率0.32%,振幅4.90%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.11%。其相关个股中,Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为3903.44%、1443.10%、1104.23%,振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.,振幅分别为421.88%、133.16%、119.83%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711003228941f5de8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711003228941f5de8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FULC","LENZ","BK4139"],"gpt_icon":0},{"id":"2450102047","title":"Fulcrum Therapeutics, Inc.盘中异动 急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450102047","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450102047?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:05","pubTimestamp":1720541157,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时05分,Fulcrum Therapeutics, Inc.股票出现异动,股价急速拉升5.12%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.72%。其相关个股中,Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃,换手率分别为9732.42%、1892.75%、306.77%,振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为327.50%、196.29%、134.00%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100005579681b307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100005579681b307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","FULC","BK4139"],"gpt_icon":0},{"id":"2446533295","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报6.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446533295","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446533295?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:48","pubTimestamp":1719496085,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时48分,Fulcrum Therapeutics, Inc.股票出现异动,股价快速上涨5.02%。截至发稿,该股报6.48美元/股,成交量6.2981万股,换手率0.10%,振幅2.76%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214806941f1d2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214806941f1d2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","FULC"],"gpt_icon":0},{"id":"2446878558","title":"Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.05%报6.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446878558","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446878558?lang=zh_cn&edition=full","pubTime":"2024-06-26 02:49","pubTimestamp":1719341355,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日02时49分,Fulcrum Therapeutics, Inc.股票出现波动,股价大幅跳水5.05%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.67%。其相关个股中,Effector Therapeutics Inc C/Wts 31/12/2025 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃,换手率分别为1128.96%、237.74%、180.32%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.,振幅分别为272.73%、77.13%、47.00%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626024915aef68b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626024915aef68b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FULC"],"gpt_icon":0},{"id":"2442552475","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨6.08%报7.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552475","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442552475?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199131,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分,Fulcrum Therapeutics, Inc.股票出现波动,股价大幅上涨6.08%。截至发稿,该股报7.85美元/股,成交量2.392万股,换手率0.04%,振幅2.03%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大,Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为37.91%、19.26%、3.70%,振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc,振幅分别为21.10%、20.93%、8.28%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213212af8d2f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213212af8d2f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","FULC"],"gpt_icon":0},{"id":"2438223372","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438223372","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438223372?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:31","pubTimestamp":1716903107,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时31分,Fulcrum Therapeutics, Inc.股票出现异动,股价急速拉升10.26%。截至发稿,该股报7.95美元/股,成交量5.7026万股,换手率0.09%,振幅3.47%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.82%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大,Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃,换手率分别为18.02%、7.41%、6.95%,振幅较大的相关个股有Corcept医疗、维罗纳制药、Hillevax, Inc.,振幅分别为13.15%、8.52%、8.46%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213147956f1634&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213147956f1634&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FULC","LENZ","BK4139"],"gpt_icon":0},{"id":"2436717753","title":"Fulcrum Therapeutics(FULC.US)获坎托菲茨杰拉德公司首次覆盖,给予增持评级, 目标价23.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2436717753","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436717753?lang=zh_cn&edition=full","pubTime":"2024-05-20 19:55","pubTimestamp":1716206149,"startTime":"0","endTime":"0","summary":"Fulcrum Therapeutics(FULC.US)获坎托菲茨杰拉德公司首次覆盖,给予增持评级, 目标价23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405201955548b1b81ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405201955548b1b81ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC"],"gpt_icon":0},{"id":"2436981531","title":"Fulcrum Therapeutics, Inc.2024财年第一财季实现净利润-26.87百万美元,同比减少8.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436981531","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436981531?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:06","pubTimestamp":1716134782,"startTime":"0","endTime":"0","summary":"3月31日,Fulcrum Therapeutics, Inc.公布财报,公告显示公司2024财年第一财季净利润为-26.87百万美元,同比减少8.43%;其中营业收入为0.00美元,每股基本收益为-0.43美元。机构评级:截至2024年3月31日,当前有8家机构对Fulcrum Therapeutics, Inc.目标价做出预测,其中目标均价为14.88美元,其中最低目标价为5.00美元,最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200006298b185da1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200006298b185da1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC"],"gpt_icon":0},{"id":"2435516876","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.85%报7.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435516876","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435516876?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:31","pubTimestamp":1715693475,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时31分,Fulcrum Therapeutics, Inc.股票出现异动,股价急速上涨5.85%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。消息层面,截至21时31分,Fulcrum Therapeutics, Inc.股票正面舆情新闻比例50%。该信息摘要如下:HC Wainwright & Co.:重申Fulcrum Therapeutics评级,由买入调整至买入评级, 目标价17.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131158b07d67a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131158b07d67a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","FULC"],"gpt_icon":0},{"id":"2435568188","title":"美国研究综述-Akoya Biosciences、波士顿啤酒公司、胜利资本控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2435568188","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435568188?lang=zh_cn&edition=full","pubTime":"2024-05-14 15:22","pubTimestamp":1715671336,"startTime":"0","endTime":"0","summary":" 路透5月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Akoya Biosciences、波士顿啤酒公司和 Victory Capital Holdings。要点 * Akoya Biosciences Inc :Canaccord Genuity将目标价从10美元下调至6美元 * 波士顿啤酒公司 :杰富瑞将目标价从335美元上调至360美元 * Fortrea Holdings Inc :Evercore ISI将目标价从43美元下调至31美元 * Medical Properties Trust Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","VCTR","SG9999011175.SGD","BK4583","CHUY","APDN","BK4203","MPW","SG9999003800.SGD","EMR","BK4568","CTRE","JELD","NHI","LEGN","GPRE","BK4096","BBIO","STZ","JXN","OBDC","CDNA","BHF","FIVE","NOTV","IOVA","FTRE","LU2249611893.SGD","BK4566","BK4120","NGNE","BK4551","CIVB","BK4007","FULC","BMRN","AKYA","MSGE","NBIX","BK4135","SAM","DH","LOB","MRNA","ATLC","NNI","ARIS","CMPX","BK4121","AGL"],"gpt_icon":0},{"id":"2435459300","title":"高盛:上调Fulcrum Therapeutics(FULC.US)评级,由中性调整至买入评级, 目标价15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435459300","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435459300?lang=zh_cn&edition=full","pubTime":"2024-05-14 04:45","pubTimestamp":1715633159,"startTime":"0","endTime":"0","summary":"高盛:上调Fulcrum Therapeutics(FULC.US)评级,由中性调整至买入评级, 目标价15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140446008b0371d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140446008b0371d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","LENZ"],"gpt_icon":0},{"id":"2435437727","title":"BUZZ--美国股票走势-Annexon、MKS Instruments、Robinhood","url":"https://stock-news.laohu8.com/highlight/detail?id=2435437727","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435437727?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:09","pubTimestamp":1715616586,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 5月13日 - 美国股指周一走高,在近期连续上涨后接近纪录高位,投资者在等待本周的关键通胀数据,以判断2024年降息的可能性。美东时间 上午 11:58,道琼斯工业平均指数 下跌0.02%,报39,505.32点。标普500指数 上涨0.01%,报5,223.42点;纳斯达克综合指数 上涨0.26%,报16,383.04点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","MNQmain","AZO","MKSI","DOG","DXD","NQmain","SRG",".DJI","RIOT","PENN","SEDG","DDM","EQR","QLD","GME","BUZZ",".IXIC","SQQQ","AMAT","ANNX","PR","ACIU","RXRX","QQQ","FANG","DJX","LU0557290698.USD","SDOW","OKE","AAPL","MARA","QID","INCY","TQQQ","MSTR","NSC","SQSP","FTRE","PSQ","UDOW","COP","AVB","FULC","XOM","GE","CVX","GOOGL","KVUE","HOOD"],"gpt_icon":0},{"id":"2435373047","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨11.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435373047","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435373047?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:32","pubTimestamp":1715607153,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时32分,Fulcrum Therapeutics, Inc.股票出现异动,股价快速拉升11.71%。截至发稿,该股报8.35美元/股,成交量27.5381万股,换手率0.44%,振幅2.81%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.94%。其相关个股中,Ac Immune Sa、Nutriband Inc C/Wts 、Tevogen Bio Holdings Inc.涨幅较大,Allarity Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Reneo Pharmaceuticals, Inc.较为活跃,换手率分别为22.77%、15.55%、13.62%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc.、Ac Immune Sa,振幅分别为26.92%、13.20%、10.82%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132132338b01b307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132132338b01b307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","FULC"],"gpt_icon":0},{"id":"2435378415","title":"BUZZ--美国股票走势-GameStop, AC Immune , Fulcrum Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2435378415","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435378415?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:26","pubTimestamp":1715606809,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 5月13日 - 美国股指周一将高开,在近期上涨后接近历史最高点,投资者正在等待本周的关键通胀数据,以判断2024年降息的可能性。美东时间 上午 9:19,道指电子盘 上涨0.28%,报39,754点。标普500指数小型股 上涨0.30%,报5262.25点;纳斯达克100指数小型股 上涨0.40%,报18327.25点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVX","LU1551013342.USD","SG9999014575.USD","BK4538","LU0494093205.USD","NSC","FULC","BK4533","GME","GOOGL","LU0130103400.USD","COP","BK4534","BUZZ","SEDG","IE00B1XK9C88.USD","LU0648001328.SGD","LU2756315664.SGD","KVUE","LU0792757196.USD","LU1201861249.SGD","BK4121","BK4147","LENZ","LU0256863811.USD","ACIU","LU0353189680.USD","BK4007","GE","FTRE","LU0648000940.SGD","RXRX","PR","LU0980610538.SGD","LU1066051498.USD","XOM","BK4201","IE00BKDWB100.SGD","LU0868494617.USD","BK4532","AC","LU1201861165.SGD","LU0528227936.USD","LU1074936037.SGD","LU1261432733.SGD","SRG","FANG","LU0266512127.USD","LU0943347566.SGD","BK4539"],"gpt_icon":0},{"id":"2435237849","title":"BUZZ--美国股票走势-GameStop, AC Immune , Fulcrum Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2435237849","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435237849?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:26","pubTimestamp":1715606809,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 5月13日 - 美国股指周一将高开,在近期上涨后接近历史最高点,投资者正在等待本周的关键通胀数据,以判断2024年降息的可能性。美东时间 上午 9:19,道指电子盘 上涨0.28%,报39,754点。标普500指数小型股 上涨0.30%,报5262.25点;纳斯达克100指数小型股 上涨0.40%,报18327.25点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","ACIU","LU1551013342.USD","SG9999014575.USD","BK4147","GOOGL","BK4201","LU0256863811.USD","PR","LU0648001328.SGD","BK4121","AC","BK4532","SRG","IE00B1XK9C88.USD","FTRE","LU1261432733.SGD","LU1066051498.USD","NSC","SEDG","GME","LU0980610538.SGD","BUZZ","BK4539","LU0130103400.USD","LU0868494617.USD","FANG","LU1074936037.SGD","BK4533","LU0494093205.USD","LU0528227936.USD","LU0648000940.SGD","LU0943347566.SGD","XOM","GE","RXRX","LU0353189680.USD","COP","LU1201861249.SGD","CVX","LU2756315664.SGD","LU0266512127.USD","LU1201861165.SGD","BK4007","LU0792757196.USD","FULC","KVUE","BK4538","IE00BKDWB100.SGD","LENZ"],"gpt_icon":0},{"id":"2435132707","title":"BUZZ-Fulcrum Therapeutics 因与赛诺菲达成肌肉疾病药物许可协议而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2435132707","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435132707?lang=zh_cn&edition=full","pubTime":"2024-05-13 20:57","pubTimestamp":1715605069,"startTime":"0","endTime":"0","summary":" 5月13日 - ** Fulcrum Therapeutics 股价盘前上涨13.8%至8.50美元** 该公司与赛诺菲 签署了 协议,开发和商业化其治疗面囊肱肌营养不良症的实验性药物** FULC 将获得 8000 万美元的预付款,并有资格获得9.75 亿美元的潜在里程碑和特许权使用费。** 赛诺菲将在美国以外的所有地区对药物 losmapimod 进行商业化,而 FULC 将保留在美国的全部商业化权利。** FSHD是一种遗传性肌肉疾病,会使面部、肩部、上臂和小腿的肌肉变弱和萎缩。** 截至上次收盘,股价累计上涨 10.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FULC","BK4139","BK4007","LENZ","BUZZ"],"gpt_icon":0},{"id":"2430868382","title":"Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430868382","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430868382?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:40","pubTimestamp":1714052400,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时40分,Fulcrum Therapeutics, Inc.股票出现波动,股价快速下挫5.22%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.03%。其相关个股中,Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大,Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃,换手率分别为941.63%、186.00%、7.25%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达,振幅分别为40.85%、25.31%、14.75%。Fulcrum Therapeutics, Inc.公司简介:Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252140007a55b3d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252140007a55b3d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","BK4007","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulcrumtx.com","stockEarnings":[{"period":"1week","weight":-0.0012},{"period":"1month","weight":0.2327},{"period":"3month","weight":0.1696},{"period":"6month","weight":0.1561},{"period":"1year","weight":1.0619},{"period":"ytd","weight":0.1852}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulcrum Therapeutics, Inc.于2015年8月18日在特拉华州注册成立。他们是一家临床阶段的生物制药公司,致力于改善未满足医疗需求的遗传性疾病患者的生活,最初的重点是罕见疾病。他们开发了一种专有产品引擎,用于系统地识别和验证可能调节基因表达的细胞药物靶点,以治疗遗传定义疾病的已知根本原因。他们正在使用他们的产品引擎来识别可被小分子吸毒的目标,而不管基因错误表达的特定潜在机制。他们已经确定了治疗面肩肱型肌营养不良症(FSHD)和某些血红蛋白病(即镰状细胞病,SCD和b-地中海贫血)的根本原因的药物靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.093943},{"month":2,"riseRate":0.6,"avgChangeRate":0.007062},{"month":3,"riseRate":0.2,"avgChangeRate":0.022339},{"month":4,"riseRate":0.2,"avgChangeRate":-0.189757},{"month":5,"riseRate":0.6,"avgChangeRate":0.060108},{"month":6,"riseRate":0.4,"avgChangeRate":-0.04331},{"month":7,"riseRate":0.6,"avgChangeRate":0.042621},{"month":8,"riseRate":0.6,"avgChangeRate":0.600813},{"month":9,"riseRate":0.4,"avgChangeRate":-0.08923},{"month":10,"riseRate":0.2,"avgChangeRate":-0.104085},{"month":11,"riseRate":0.8,"avgChangeRate":0.266909},{"month":12,"riseRate":1,"avgChangeRate":0.212178}],"exchange":"NASDAQ","name":"Fulcrum Therapeutics","nameEN":"Fulcrum Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulcrum Therapeutics,FULC,Fulcrum Therapeutics股票,Fulcrum Therapeutics股票老虎,Fulcrum Therapeutics股票老虎国际,Fulcrum Therapeutics行情,Fulcrum Therapeutics股票行情,Fulcrum Therapeutics股价,Fulcrum Therapeutics股市,Fulcrum Therapeutics股票价格,Fulcrum Therapeutics股票交易,Fulcrum Therapeutics股票购买,Fulcrum Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}